Concepedia

P.A. Robson

PR

Statistics

Publications

11

Citations

724

H-Index

11

Active since

1980

Affiliations

Institut Curie(Current)

Vantia (United Kingdom)

Inserm

Precision Varionic International (United Kingdom)

P.A. Robson is an author at Institut Curie specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1980–2016

11

Publications

11

Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound

Richard A. Williamson, Christopher Yea, P.A. Robson et al. · Journal of Biological Chemistry · 1995 · 196 citations · Full text

Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide

Jean‐Michel Bruneau, Christopher Yea, Sylviane Spinella-Jaegle et al. · Biochemical Journal · 1998 · 146 citations · Full text

GnRH Antagonists:  A New Generation of Long Acting Analogues Incorporating<i>p</i>-Ureido-phenylalanines at Positions 5 and 6

Guangcheng Jiang, Jacek Stalewski, Robert Galyean et al. · Journal of Medicinal Chemistry · 2000 · 110 citations · Full text

, , +16

Biochemical investigations into the mode of action of trazodone

S. Clements-Jewery, P.A. Robson, L.J. Chidley · Neuropharmacology · 1980 · 70 citations

, , +7

Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide.

R. Williamson, Christopher Yea, P.A. Robson et al. · PubMed · 1996 · 41 citations

, , +6

1–5 of 11